Advertisement

Topics

Latest "Approves Cardio Revolutionary Diagnostic Heart Device" News Stories

13:22 EST 19th November 2018 | BioPortfolio

Here are the most relevant search results for "Approves Cardio Revolutionary Diagnostic Heart Device" found in our extensive news archives from over 250 global news sources.

More Information about Approves Cardio Revolutionary Diagnostic Heart Device on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Approves Cardio Revolutionary Diagnostic Heart Device for you to read. Along with our medical data and news we also list Approves Cardio Revolutionary Diagnostic Heart Device Clinical Trials, which are updated daily. BioPortfolio also has a large database of Approves Cardio Revolutionary Diagnostic Heart Device Companies for you to search.

Showing "Approves Cardio Revolutionary Diagnostic Heart Device" News Articles 1–25 of 13,000+

Monday 19th November 2018

Proteome Sciences Plc PRM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryProteome Sciences Plc Proteome Sciences is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expressions and modifications that help define processes for improving research outcomes. The company detects and...


Titan Medical to Present at the 30th Annual Piper Jaffray Healthcare Conference

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), today announced that David McNally, President and CEO of the Company, will present a corporate ...

Global POC Urinalysis Market 2018-2022 | Rising Prevalence of Nephropathic Disorders and UTIs to Boost Demand | Technavio

The global POC Urinalysis market 2018-2022 is expected to post a CAGR of more than 3% during the forecast period, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181119005353/en/


Upwell Health CEO Alison Wistner Wins Bronze Award at the 15th Annual Stevie® Awards for Women in Business

CEO Honored in Female Entrepreneur of the Year Category Upwell Health, a leading provider of healthcare services, support, and solutions for people living with chronic conditions, today announced that CEO Alison Wistner has been named the Bronze Stevie Award winner in the Female Entrepreneur of the Year category at the 15th annual Women in Business Awa...

Pavmed Inc PAVM Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryPavmed Inc Pavmed is a medical device company. The company offers disposable infusion pumps, shortterm catheters, percutaneous and tissue ablation devices, and longterm vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear...

FDA Approves Novartis’ Promacta for first-line SAA and Grants Breakthrough Therapy Designation for Additional New Indication

Basel, November 16, 2018 – Novartis announced today that the US Food and Drug Administration (FDA) has expanded the label for Promacta® (eltrombopag) to include first-line treatment for adults and pediatric patients two years and older with SAA in combination with standard immunosuppressive therapy (IST). Promacta, which is marketed as Revolade® in most countries outside the US, is an ...

FDA Approves New Drug to Treat Travelers' Diarrhea

NewsTravelers' diarrhea is the most common travel-related illness, affecting an estimated 10 to 40 percent of travelers worldwide each year.Cont

Affordable Designer Prescription Eyewear from Warby Parker Now Available to People Enrolled in UnitedHealthcare Medicare Advantage Plans

Expanded network relationship enables approximately 2 million UnitedHealthcare Medicare Advantage plan participants to purchase custom eyewear for little or no out-of-pocket cost UnitedHealthcare Medicare Advantage plan participants are the first Medicare beneficiaries to have network access to Warby Parker Warby Pa...

FDA Approves Adcetris Plus Chemo for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas

BOTHELL, Wash.–(BUSINESS WIRE)–Nov. 16, 2018– Seattle Genetics, Inc. (Nasdaq:SGEN) today announced a new approval for ADCETRIS® (brentuximab vedotin) in combination with CHP chemotherapy (cyclophosphamide, doxorubicin, prednisone) from the U.S. Food and Drug Administration (FDA) for adults with previously untreated systemic anaplastic large cell lymphoma (sALCL) or other CD...

Anthem Foundation Awards Additional $23 Million to Nonprofits Supporting Efforts to Improve Health of Communities Nationwide

More than $53 million in grants at work addressing critical health issues facing Americans The Anthem Foundation announced today an additional commitment of $23 million in new grants this year aimed at their continued efforts to improve the health and wellness of communities across the country. The latest funding brings the Foundation’s current commu...

Snow Park Capital Partners’ Rachel Ward Raises More Than $50,000 for “Team Meg”

Snow Park Capital Partners L.P. (“Snow Park”), a leading investment management firm focused on publicly-traded real estate securities, today announced that Rachel Ward, the firm’s Manager of Investor Relations and Marketing, raised nearly $54,000 to date for Team Meg, a charity which supports cancer survivorship research for The Meg Berté Owen Survi...

Blockchain and Location-Verification Company XYO Network Announces Partnerships with Run2Play and A-B Engineering

New Partnerships Drive Improved Hardware Solutions and Improve Location-Based Features of Powerful Fitness Platform XYO Network, the technology bringing blockchain to the real world, today announced partnerships with

Zingbox Wins Gold as Most Innovative Company of the Year in 15th Annual Stevie Awards for Women in Business

Leading IoT Security Provider and its CTO Dr. May Wang Recognized With Six Awards, Including a Gold, Four Silvers and a Bronze Zingbox, the provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform and a leader in healthcare IoT research, announced today that the company and its CTO and co-founder Dr. May Wang have won...

Cloudponics Announces Holiday Discount For Leading Product, GroBox

Customers Can Save Up To $420 Off Of Fully-Automated Growing Device SAN FRANCISCO (PRWEB) November 19, 2018 Cloudponics, maker of the GroBox, the intelligent, fully-automated IoT aeroponic plant growing system for the home, today announced a discount of $420 for its industry-leading product during the holiday season. Customers can save up to $420 off the $2690 GroBox if paid in full, with other ...

CardioDx Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryCardioDx Inc CardioDx is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company's flagship product, Corus CAD gene expression test is used for assessing obstructive CAD Coronary Artery Disease in patients with chest pain. The company, along with its ...

Proteus Digital Health Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryProteus Digital Health Inc Proteus is a digital medicine company that develops and sells medicines for chronic diseases through inhouse research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digital medicine, automatically gathers and communicates information about medication taking, activity and rest patt...

Athera Biotechnologies AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryAthera Biotechnologies AB Athera is a clinical stage biopharmaceutical company that focuses on the development of antiinflammatory biological candidate drugs for the prevention and treatment of immunovascular disease. The company develops a proprietary clinical development stage program, PCmAb, a human monoclonal antibody used to treat vascular disease, peripheral artery disease, heart fail...

SIFI SpA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummarySIFI SpA SIFI is an integrated ophthalmic company that focuses on eye care products. It develops, manufactures and markets pharmaceutical products, diagnostic instruments and surgical equipment for the prevention and treatment of the ocular pathologies. SIFI develops its products in various dosage forms including ointments, eye drops, pills and capsules. Its products find application in the...

Advocate Health Care Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryAdvocate Health Care Advocate Health is a nonprofit health system that provides health care services. It provides health care services such as inpatient acute and nonacute care, primary and specialty physician services and various outpatient services to communities in Illinois. The organization provides services in the areas of cancer neurology, orthopedics and women care. Its heart Institu...

Integrated DNA Technologies Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryIntegrated DNA Technologies Inc IDT is a biotechnology company that develops diagnostic test products. The company's products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services such as analytics, custom label, OEM, and packaging and formulation. IDT offers diagnostic tests for gen...

Aushon BioSystems Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryAushon BioSystems Inc Aushon is a medical device provider that provides biomarker measurement and analysis products. The company offers biomarker therapeutic areas in microarray printing technology. It provides products such as ciraplex assay, cirascan imaging and cirasoft analysis and cira services, among others. Aushon offers services such as ciraplex ULTRA ultrasensitive assay, cirascan ...

Asahi Kasei Pharma Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryAsahi Kasei Pharma Corp Asahi Kasei Pharma, a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The company's portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescription drugs are used for the treatment of osteoporosis pain, disseminated intravascular coagulation, b...

Blue Earth Diagnostics Announces Results of Investigational Phase 3 Blinded Image Evaluation Study of 18F-Fluciclovine PET Imaging in Glioma

– Presented at 23rd Annual Scientific Meeting of the Society for Neuro-Oncology – Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced results from an investigational Phase 3 blinded image evaluation (BIE) study of the diagnostic efficacy of 18F-fluciclovine positron emission tomography (PET) imaging, as an adjunct to ma...

Invivoscribe, Inc.: Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japan

SAN DIEGO, Nov. 19, 2018to the PMDA (Pharmaceuticals and Medical Devices Agency) as the companion diagnostic for quizartinib, which follows Daiichi Sankyo's PMDA application for quizartinib in Japa...

Ono Pharmaceutical Co Ltd 4528 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryOno Pharmaceutical Co Ltd Ono Pharmaceutical is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzheimer's disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others....


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks